Analysts have turned bearish on CanSino Biologics, slashing ...
Analysts have turned bearish on CanSino Biologics, slashing next year's revenue estimates and predicting losses. Despite downgrades, they still foresee CanSino outpacing the broader industry.
CanSino Biologics Inc. (HKG:6185) Analysts Are Reducing Their Forecasts For Next Year
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3148Followers
0Following
7900Visitors
Follow